Repligen (RGEN) Current Deferred Revenue (2011 - 2026)

Repligen (RGEN) has 15 years of Current Deferred Revenue data on file, last reported at $18.3 million in Q1 2026.

• On a quarterly basis, Current Deferred Revenue fell 13.68% year-over-year to $18.3 million in Q1 2026; TTM through Mar 2026 was $18.3 million, a 13.68% decrease from a year earlier, with the FY2025 full-year figure at $14.6 million, up 10.31% from the prior year.
• Current Deferred Revenue for Q1 2026 stood at $18.3 million, up from $14.6 million in the prior quarter.
• Over the last five years, Current Deferred Revenue for RGEN reached as high as $31.6 million in Q2 2023 and fell as low as $13.2 million in Q4 2024.
• Historically, Current Deferred Revenue has averaged $20.1 million across 5 years, with a median of $19.3 million in 2022.
• Across the five-year window, Current Deferred Revenue soared 54.95% in 2023 and tumbled 55.64% in 2024, its largest moves.
• Year by year, Current Deferred Revenue stood at $19.3 million in 2022, then declined by 11.49% to $17.1 million in 2023, then decreased by 22.41% to $13.2 million in 2024, then rose by 10.31% to $14.6 million in 2025, then grew by 25.32% to $18.3 million in 2026.
• Per Business Quant data, the three most recent Current Deferred Revenue figures were $18.3 million in Q1 2026, $14.6 million in Q4 2025, and $15.7 million in Q3 2025.